New trial to repurpose cancer drug for COVID-19 patients
The trial will study the use of ruxolitinib, a JAK inhibitor, to investigate its effect on reducing complications in deteriorating COVID-19 patients
The trial will study the use of ruxolitinib, a JAK inhibitor, to investigate its effect on reducing complications in deteriorating COVID-19 patients
A rare lung disease drug is being trialed to help fight COVID-19
The MSA Series expands on Spellman’s highly regarded MS Series high voltage modules
Advance your COVID-19 research with positive and negative SARS-CoV-2 samples
Read the highlights and Q&A from part two of the webinar series: Innovations in Laboratory Efficiency and Analytical Workflows
Find out how small data systems can create new possibilities for better, more verifiable science in your lab in this SelectScience webinar
Automated “lateral flow” dispensing technology is vital step in rapid point-of-care antibody test production
Olympus imaging systems empower next-generation cancer research at USC’s Ellison Institute
The study is expected to begin enrolling in June with a target of approximately 450 patients globally
Company to make the device available through broad range of healthcare, state, employer and consumer-initiated channels
The RNAdvance Viral XP is a RNA extraction kit validated for use in infectious disease and real-time PCR virus research
The CXT 353 is designed to minimize aerosol exposure to viral samples like COVID-19
Dr. Ofer Sharon discusses a new cancer research platform designed to improve patient outcomes, cut costs, and minimize unnecessary adverse events
Harnessing the most powerful force in the fight against disease — natural human immunity